Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.0150
-0.0350 (-1.71%)
NASDAQ· Last Trade: Jul 8th, 2:16 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors